Evaluation of the Effects of Cancer Diagnosis on Smoking Behavior in Cancer Patients and Their Relatives

Year 2025, Volume: 8 Issue: 2, 149 - 154, 30.06.2025

Zeynep Kahyaoğlu , Filiz Çay Şenler

https://doi.org/10.36516/jocass.1522913

Abstract

SUMMARY
Introduction and Objective: Smoking plays a role in the development of many diseases, such as atherosclerotic cardiovascular diseases, COPD and cancer. We aimed to examine the smoking behaviors of patients and their relatives who are followed up and treated after cancer diagnosis and to identify associated factors.
Materials and Methods: Between August 2012 and January 2013, 211 patients and 208 relatives of patients who were admitted to the medical oncology department of Ankara University Faculty of Medicine between August 2012 and January 2013 and whose follow-up and treatment continued in the ward or outpatient clinic were included in this study. A survey consisting of 25 questions was applied to the patients and 24 questions to their relatives. Beck Depression Inventory was added to the last part of the questionnaire in both groups. Three months after the completion of the forms, the participants were called again, and their smoking behaviors were questioned again.
Results: Pre-diagnosis smoking prevalence was higher among patients than their relatives (62.6% vs. 45.7%). Patients started smoking at an earlier age, and their daily cigarette consumption was significantly higher than that of their relatives. The amount of cigarettes smoked per day increased significantly as the age of initiation decreased in both patient and relative groups. The rate of smoking cessation /reduction was significantly higher in patients than in relatives (97.2% vs. 26.6%). Physicians were significantly more likely to recommend smoking cessation to patients than relatives (41.9% vs. 20%). Beck depression scores were significantly higher in patients and singles than in patients' relatives and married patients. No significant difference was found between smoking attitude and depression scores in patients and relatives.
Conclusion: Smoking is one of the most important preventable factors that threaten human health. It is imperative to develop effective strategies in the fight against smoking rapidly. In this context, physicians' recommendations for smoking cessation are as effective as many other methods. After the diagnosis of cancer, both patients and their relatives showed a tendency to quit or reduce smoking, with patients being significantly more likely.

Keywords

Cancer patients, smoking cessation, relatives of cancer patients, depression.

References

• 1.Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008;57(45):1226-8.
• 2.Brawley OW. Avoidable cancer deaths globally. CA Cancer J Clin. 2011;61(2):67-8. [Crossref]
• 3.International Agency for Research on Cancer. Tobacco smoking. IARC Monogr Eval Carcinog Risk Chem Hum. 1986;38:1-397.
• 4.U.S. Department of Health and Human Services. The health consequences of smoking: 25 years of progress. A report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989. DHHS Publication No. (CDC) 89-8411.
• 5.Erbaydar T, Lawrence S, Dağlı E, Hayran O, Collishaw NE. Influence of social environment in smoking among adolescents in Turkey. Eur J Public Health. 2005;15(4):404-10. [Crossref]
• 6.McBride PE. The health consequences of smoking: cardiovascular diseases. Med Clin North Am. 1992;76(2):333-53. [Crossref]
• 7.U.S. Department of Health and Human Services. The health benefits of smoking cessation: a report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1990. DHHS Publication No. (CDC) 90-8416.
• 8.Erguder T, Cakir B, Aslan D, Warren CW, Jones NR, Asma S. Evaluation of the use of Global Youth Tobacco Survey (GYTS) data for developing evidence-based tobacco control policies in Turkey. BMC Public Health. 2008;8 Suppl 1:S4. [Crossref]
• 9.Mimioğlu MM. Research on the systemic effects of smoking. Turk J Hyg Exp Biol. 1986;43(2):85-9.
• 10.Hoffman D, Rathkamp G, Nesnow S, Wynder EL. Fluoranthenes: quantitative determination in cigarette smoke, formation by pyrolysis, and tumor-initiating activity. J Natl Cancer Inst. 1972;49(4):1165-75.
• 11.Nandi M, Jick H, Slone D, Shapiro S, Lewis GP. Cadmium content of cigarettes. Lancet. 1969;2(7634):1329-30. [Crossref]
• 12. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001;357(9272):1929-32. [Crossref]
• 13.Bolam B, West R, Gunnell D. Does smoking cessation cause depression and anxiety? Findings from the ATTEMPT cohort. Nicotine Tob Res. 2011;13(3):209-14. [Crossref]
• 14.Gilman AG, Goodman LS, Gilman A, editors. Goodman and Gilman's The pharmacological basis of therapeutics. 6th ed. New York: Macmillan Publishing Co.; 1980. p. 558.
• 15. Tierney LM, McPhee SJ, Papadakis MA, editors. Current medical diagnosis & treatment 2010. 49th ed. New York: McGraw-Hill Medical; 2010. p. 6-8.
• 16. Rubins J, Unger M, Colice GL; American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest. 2007;132(3 Suppl):355S-367S. [Crossref]
• 17. Centers for Disease Control and Prevention (CDC). State-specific estimates of smoking-attributable mortality and years of potential life lost - United States, 1985. MMWR Morb Mortal Wkly Rep. 1988;37(44):689-94.
• 18. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst. 2004;96(2):99-106. [Crossref]
• 19. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249(6):751-7. [Crossref]
• 20.Weaver KE, Rowland JH, Augustson E, Atienza AA. Smoking concordance in lung and colorectal cancer patient-caregiver dyads and quality of life. Cancer Epidemiol Biomarkers Prev. 2011;20(2):239-48. [Crossref]
• 21. Carmelli D, Swan GE, Robinette D, Fabsitz R. Genetic influence on smoking--a study of male twins. N Engl J Med. 1992;327(12):829-33. [Crossref]
• 22. National Committee on Smoking and Health [Internet]. [cited 2025 Jun 30].
• 23.Fontham ET, Correa P, Reynolds P, Wu-Williams A, Buffler PA, Greenberg RS, et al. Environmental tobacco smoke and lung cancer in nonsmoking women: a multicenter study. JAMA. 1994;271(22):1752-9. [Crossref]
• 24. Balduyck B, Sardari Nia P, Cogen A, Dockx Y, Lauwers P, Hendriks J, et al. The effect of smoking cessation on quality of life after lung cancer surgery. Eur J Cardiothorac Surg. 2011;40(6):1432-8. [Crossref]